Cardiology – Page 6

Precision Medicine in Dilated Cardiomyopathy: Integrating Genetic Counselling and Testing into Clinical Practice

By MedXY 03/20/2026

This review explores the transition of genetic testing in dilated cardiomyopathy from family risk assessment to a central tool for clinical decision-making and personalized risk stratification.

Cardiology news Pathology & Lab Medicine

Natural History of Patients With Histologically Proven Acute Eosinophilic Myocarditis

By MedXY 03/20/2026

This article explores a major international study of 156 acute eosinophilic myocarditis patients, revealing high mortality rates, the diagnostic necessity of endomyocardial biopsy, and the critical survival benefit of early immunosuppressive therapy despite frequently absent peripheral eosinophilia.

Cardiology news

Rethinking Mitral Regurgitation in Hypertrophic Cardiomyopathy: Lessons from the REVEAL-HCM Study

By MedXY 03/20/2026

The REVEAL-HCM study demonstrates that the prognostic impact of mitral regurgitation varies significantly across HCM subtypes, with notable risk in nonobstructive and apical forms, but not in obstructive or end-stage HCM.

Cardiology news Public Health

Is Semaglutide Worth the Cost? Evaluating the Economic Reality of GLP-1s for Heart Disease Prevention

By MedXY 03/20/2026

A comprehensive simulation study evaluates the cost-effectiveness of semaglutide for secondary cardiovascular prevention in US adults without diabetes, finding significant health benefits but highlighting the need for price reductions to ensure economic sustainability.

Cardiology news

Mechanical Heart Valves in Pregnancy: Navigating the High Risk of Thrombosis and the Biological Valve Advantage

By MedXY 03/20/2026

The ESC EORP ROPAC III registry highlights a stark contrast in pregnancy outcomes between mechanical and biological heart valves, revealing that only 54% of women with mechanical valves achieve an uncomplicated live birth, largely due to anticoagulation-related complications.

Cardiology news Public Health

Ethnic Minority Patients with Heart Failure in England Achieve Superior Survival: The Crucial Role of Specialist Care and Medication Adherence

By MedXY 03/20/2026

A large-scale analysis of 239,890 patients in England reveals that Black, Asian, and mixed-ethnicity patients hospitalized for heart failure have significantly lower mortality rates than White patients, largely due to better pharmacological management and specialist care within a universal healthcare system.

Cardiology Internal Medicine news

Memantine for Premature Atrial Contractions: A Phase 2 Randomized Clinical Trial

By MedXY 03/20/2026

This phase 2 trial demonstrates that memantine, an NMDA receptor antagonist, significantly reduces premature atrial contractions (PACs) and nonsustained atrial tachycardia burden, suggesting the cardiac glutamatergic system as a novel therapeutic target for atrial arrhythmias.

Cardiology news

LOXL2 Inhibition: A New Frontier in Treating LMNA-Related Dilated Cardiomyopathy

By MedXY 03/17/2026

Recent research identifies LOXL2 as a primary driver of fibrosis in LMNA-mutated dilated cardiomyopathy. The study demonstrates that Simtuzumab, a LOXL2 inhibitor, effectively prevents extracellular matrix remodeling and preserves cardiac function in both human iPSC and murine models.

Cardiology Clinical Updates Diabetes & Endocrinology Internal Medicine news

The Rising Tide of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Synthesis of Medication Eligibility and Clinical Implementation

By MedXY 03/17/2026

This review synthesizes population-level data on the eligibility for GLP-1RAs, SGLT2is, and nsMRAs, highlighting that over 60% of US adults meet indications for these transformative therapies.

Cardiology news

Transcatheter Edge-to-Edge Repair Superior to Medical Therapy in Atrial Functional Mitral Regurgitation: Evidence from Real-World Registries

By MedXY 03/17/2026

A propensity score-based study demonstrates that transcatheter edge-to-edge repair (TEER) significantly reduces mortality and heart failure hospitalizations in patients with atrial functional mitral regurgitation compared to medical therapy, especially when achieving low residual regurgitation.

Cardiology Clinical Updates news

Mapping the Plasma Proteome to Predict Venous Thromboembolism: Evidence from Multi-Cohort Proteomic Profiling and Causal Inference

By MedXY 03/17/2026

This review synthesizes cutting-edge findings from multi-ethnic longitudinal cohorts using high-throughput proteomics to identify novel biomarkers and causal pathways for venous thromboembolism, moving beyond traditional clotting factors.

Cardiology news

TAVI Superiority in Women with Aortic Stenosis: New Evidence from the DEDICATE-DZHK6 Trial

By MedXY 03/17/2026

A subgroup analysis of the DEDICATE-DZHK6 trial reveals that TAVI significantly reduces the 1-year risk of death or stroke compared to SAVR in both sexes, with particularly pronounced clinical benefits for women, especially regarding stroke prevention.

Cardiology Internal Medicine news

Coronary Artery Calcium Scoring Remains the Definitive Risk Stratifier for Patients With Elevated Lipoprotein(a)

By MedXY 03/17/2026

A large multicohort study involving 11,319 participants confirms that Coronary Artery Calcium (CAC) scoring effectively stratifies cardiovascular risk even in individuals with high Lipoprotein(a), providing clinical clarity for personalized preventive strategies and the management of primary prevention patients.

Cardiology Internal Medicine news

CRLF1 Secreted by Cardiac Fibroblasts: A New Driver and Potential Therapeutic Target for Hypertrophic Cardiomyopathy

By MedXY 03/17/2026

This article explores a groundbreaking study identifying CRLF1, a protein secreted by cardiac fibroblasts, as a key driver of Hypertrophic Cardiomyopathy (HCM). This paracrine signaling mechanism offers a potential universal therapeutic target for patients regardless of their specific genetic mutations.

Cardiology Clinical Updates news

Interaction Between SGLT2 Inhibition and Dietary Sodium: Insights from the CREDENCE Trial Post Hoc Analysis

By MedXY 03/15/2026

This post hoc analysis of the CREDENCE trial reveals that low-normal sodium intake increases cardiovascular risk in T2D and CKD, a risk significantly mitigated by canagliflozin, while renal protection remains consistent across sodium intake levels.

Cardiology Diabetes & Endocrinology news

Chronic Inflammation via suPAR: The Missing Link Between Diabetes and Cardiovascular Mortality

By MedXY 03/15/2026

A landmark study in Diabetes Care reveals that soluble urokinase plasminogen activator receptor (suPAR) mediates over half of the increased risk for adverse cardiovascular outcomes in patients with diabetes and coronary artery disease, surpassing traditional inflammatory markers like hs-CRP.

Cardiology Clinical Updates Diabetes & Endocrinology news

The Changing Landscape of Mortality in Diabetes: A Shift from Cardiovascular Dominance to Cancer and Dementia

By MedXY 03/14/2026

This review analyzes multinational data showing a significant decline in cardiovascular mortality among diabetes patients, alongside a concerning rise in dementia-related deaths and the emergence of cancer as a leading cause of mortality in high-income settings.

Cardiology Clinical Updates news

Residual Clinical Risk and Economic Burden in HFrEF: Insights from the Quadruple Medical Therapy Era

By MedXY 03/14/2026

This review analyzes the real-world one-year outcomes and healthcare costs for HFrEF patients on quadruple therapy, revealing significant residual risk despite optimized pharmacologic management.

Cardiology news

Moderate Mixed Aortic Valve Disease: Why Moderate Severity Carries Severe Risk

By MedXY 03/14/2026

A large-scale multicenter study demonstrates that moderate mixed aortic valve disease (MAVD) carries a mortality risk comparable to severe aortic stenosis when symptoms or left ventricular dysfunction are present, challenging current guideline-based management for these patients.

Cardiology news

Efficiency Unleashed: Real-Time Heart Teams Transform Complex CAD Management in the EHEART Trial

By MedXY 03/14/2026

The EHEART trial reveals that real-time, online heart team discussions during angiography significantly improve clinical efficiency and reduce costs for complex CAD patients, while maintaining 1-year safety outcomes noninferior to traditional face-to-face multidisciplinary meetings.